• 상하수도학회지
• /
• 제18권3호
• /
• pp.312-319
• /
• 2004

The optimum dosage control is presumably the goal of every water treatment plant. However it is difficult to determine the dosage rate of coagulant, due to nonlinearity, multivariables and slow response characteristics, etc. To deal with this difficulty, the real number genetic-fuzzy system was used in determining the dosage rate of the coagulant. The genetic algorithms are excellently robust in complex optimization problems. Since it uses randomized operators and searches for the best chromosome without auxiliary informations from a population which consists of codings of parameter set. To apply this algorithms, we made the real number rule table and membership function from the actual operation data of the water treatment plant. We determined optimum dosages of coagulant(LAS) using the fuzzy operation and compared them with the dosage rate of the actual operation data.

• 대한한방내과학회지
• /
• 제19권2호
• /
• pp.159-184
• /
• 1998

The aim of the study was the experiment of the effect that Kami-Daesihotang had on the essential hypertension and hyperlipidemia. Rats were orally administered with Kami-Daesihotang for 30days and the constituent of the plasma and serum were analysed at the 10th, 20th and 30th day from the first day of experiment, respectively. The heart rate, blood pressure, plasma renin activity, plasma level of aldosterone, catecholamine, sodium and angiotensin II were measured after an oral administration of Kami-Daesihotang in SHR. In addition, serum levels of total cholesterol, triglyceride, HDL-cholesterol, LDL-cholesterol and total lipid were measured with cholesterol-fed rats. The results were summarized as following ; 1. Single-dosage Kami-Daesihotang & double-dosage Kami-Daesihotang remarkably decreased the blood pressure in SHR. 2. Double-dosage Kami-Daesihotang were recognized as having the effect on the decreased of the pulse rate in SHR. 3. Plasma renin activity was significantly decreasd in SHR after single-dosage Kami-Daesihotang & double-dosage Kami-Daesihotang treatment. 4. Double-dosage Kami-Daesihotang considerably reduced the plasma angiotensin level in SHR. 5. Noticeable decreased of plasma norepinephrine level was showed in SHR, after single-dosage Kami-Daesihotang & double-dosage Kami-Daesihotang treatment. 6. Single-dosage Kami-Daesihotang & double-dosage Kami-Daesihotang noticeable reduced body weight in hyperlipidemia rats which had fed with 1% cholesterol. 7. Single-dosage Kami-Daesihotang & double-dosage Kami-Daesihotang had a significantly decreasing effect on serum total cholesterol in hyperlipidemia rats which had fed with 1% cholesterol. 8. Serum triglyceride level was importantly decreased in hyperlipidemia rats which had fed with 1% cholesterol, after single-dosage Kami-Daesihotang & double-dosage Kami-Daesihotang treatment. 9. Remarkable decreased of serum low density lipoprotein cholesterol level was found in hyperlipidemia rats which had fed with 1% cholesterol, after single-dosage Kami-Daesihotang & double-dosage Kami-Daesihotang treatment. 10. Double-dosage Kami-Daesihotang was showed a significantly decreasing effect on serum total lipid level in hyperlipidemia rats which had fed with 1% cholesterol. 11. Single-dosage Kami-Daesihotang noticeably reduced organ weight of liver, kidney, spleen and testis in hyperlipidemia rats which had fed with 1% cholesterol. Double-dosage Kami-Daesihotang significantly decreased organ weight of liver, kidney and spleen in hyperlipidemia rats. These Findings suggest a possible anti-hypertensive and hyperlipidemic effect of Kami-Daesihotang.

• 한국환경과학회지
• /
• 제8권5호
• /
• pp.625-631
• /
• 1999

This study was performed to determine the optimum coagulant dosing for effective treatment of raw water in Chinyang lake. Removal rates of algae and characteristics of the water according to coagulants dosage were investigated by treatment with Microcystis aeruginosa, which is a kind of blue-green algae, to the raw water below 5NTU. The coagulants dosage for maximum removal rate of algae were 30 mg/$\ell$ of Alum, 30 mg/$\ell$ of PAC and 10 mg/$\ell$ of PACS, respectively. The removal rate of algae in 30 mg/$\ell$ of PAC was highest as 85% compared with the other treatments. At the point of maximum removal rate of algae, the removal rates of turbidity were 34%, 66% and 22% in Alum, PAC and PACS, respectively. Residual Al was decreased depend upon decreasing turtidity in water by treatment of Alum or PAC, but decreased depend upon increasing turbidity in water by treatment of PACS. The removal rate of ${Mn}_{2+}$ in water was high in the order of Alum, PAC and PACS treatment. And ${Fe}_{2+}$ in water was not changed by treatemnt of these coagulants. Particle numbers distributions according to the particle size of suspended solids that were not precipitated at 8 min. of settling time after treatment of coagulants dosage for the maximum removal rate of algae were investigated. Most of the particle sizes were below 30 $\mu$m and particle numbers distributions below 10 $\mu$m were 64%, 56% and 66% by treatment of Alum, PAC and PACS, respectively. Zeta potential was in the range of -6.1~-9.7 mV at optimum coagulants dosage for algae removal.

• 대한기계학회논문집B
• /
• 제26권6호
• /
• pp.757-764
• /
• 2002

Chlorination dosage in water treatment plant of field is determined by chlorination demand experiment through two or three hours after raw water was sampled in inflow. It is impossible to continuously control for real time because the sampled water is adapted chlorination dosage after water treatment process had been proceeded. Therefore in this study, we will design informal chlorination demand system, this designed system will be experimented as to water quality and accuracy of control in various conditions. Throughout these experimental results, we will revise the system and the revised system is enable to optimal control of chlorination dosage. Finally, we have developed chlorination demand system, which can automatically determination of chlorination dosage to be determined according to variety of raw water quality inflow in water treatment plant.

• 대한기계학회:학술대회논문집
• /
• 대한기계학회 2000년도 춘계학술대회논문집B
• /
• pp.807-812
• /
• 2000

Chlorination dosage in water treatment plant of field is determined by chlorination demand experiment through two or three hours after raw water was sampled in inflow. It is impossible to continuously control fer real time because sampled water is adapted chlorination dosage after water treatment process had been proceeded. Therefore in this study, we will design informal chlorination demand system this designed system will be experimented as to water quality and accuracy of control in various conditions. Throughout these. experimental results, we will revise the system and revised system is enable to optimal control of chlorination dosage. Finally, We have developed chlorination demand system, which can automatically determination of chlorination dosage to be determined according to variety of raw water quality inflow in water treatment plant.

• 한국물환경학회지
• /
• 제28권2호
• /
• pp.300-304
• /
• 2012

It has a limitation to satisfy the phosphorus effluent criteria of 0.2 mg/L which will be reinforced from 2012 with the Biological Nutrient Removal (BNR) process. The chemical coagulation process has been operated in parallel with the biological treatment process for advanced treatment of phosphorous in the developed countries including Europe. However, the coagulation process has some disadvantages such as the desired goal may not be achieved without injecting the optimum dosage of the coagulant. This study developed the automatic control system to inject the optimum dosage of phosphorous coagulant into the coagulation process. The adopted coagulant was 10% Poly Aluminum Chloride (PAC) in this study. The automatic control system developed in this study was adopted for the treatment of the phosphorus from the effluent in SBR process. The automatic control system was composed of the data receiving part, the optimum coagulant dosage control part and the data transmit part. The result of the phosphorous advanced treatment of the SBR effluent using the automatic control system showed the removing efficiency over 95% consistently with the phosphorous concentration under 0.02 ~ 0.15 mg/L. The reproducibility analysis for checking the safety of automatic control system showed more than 95% correlation.

• 환경위생공학
• /
• 제18권1호
• /
• pp.41-50
• /
• 2003

Traditionally the supernatant after chemical treatment of metal acid wastewater is discharged in environment. The supernatant can be used as a coagulant as it contains effective metals. The aim of this study is to investigate the feasibility of treatment of dyeing wastewater using the supernatant after treatment by magnesium hydroxide and dolomite($Ca{\cdot}Mg(CO_3)_2$), of acidic metal wastewater. In dyeing wastewater treatment with the supernatant, optimum pH and dosage were determined. COD, turbidity and color were analyzed to evaluate the performance of treatment. In the case of magnesium hydroxide, the optimum dosage was 10%(v/v) for supernatant A and 3%(v/v) for supernatant B. Color, turbidity and COD removal was 99~100%, 85~97% and 43~53%, respectively. In the case of dolomite, the optimum dosage was 10%(v/v) for supernatant A and 3% for supernatant B. Color, turbidity and COD removal was 96~99%, 62~9l% and 52~53%, respectively.

• 대한약침학회지
• /
• 제13권3호
• /
• pp.15-46
• /
• 2010

Objectives: This study was performed to analyse the effects of Sweet Bee Venom(Sweet BV) on cardiovascular system in the conscious telemetered Beagle Dogs. Methods: All experiments were conducted at Biotoxtech Company, a non-clinical studies authorized institution, under the regulations of Good Laboratory Practice (GLP). Male Beagle dogs of 13-19 months old were chosen for the pilot study and surgical implantation was performed for conscious telemetered Beagle dogs. And after confirming condition of Beagle dogs was stable, Sweet BV was administered 4 times(first: 0.0 mg/kg, 2nd: 0.01 mg/kg, 3rd: 0.1 mg/kg, and forth: 0.5 mg/kg, one time/week) in thigh muscle of Beagle dogs. And blood pressure, heart rate, electrocardiography and clinical responses were measured. Equal amount of normal saline to the Sweet BV experiment groups was administered to the control group. Results: 1. In the analysis of body weight and taking amount, Beagle dogs did not show significant changes. 2. In the clinical observation, responses of pain and edema were showed depend on dosage of Sweet BV. 3. In the analysis of blood pressure, treatment with Sweet BV did not show significant changes in the dosage of 0.01 mg/kg, but in the dosage of 0.1 mg/kg and 0.5 mg/kg, treatment with Sweet BV increased blood pressure significantly. 4. In the analysis of heart rate, treatment of Sweet BV did not show significant changes in all dosage and period. 5. In the analysis of electrocardiography, treatment of Sweet BV was not showed significant changes in all dosage and period. Conclusion: Above findings suggest that Sweet BV is relatively safe treatment in the cardiovascular system. But in the using of over dosage, Sweet BV may the cause of increasing blood pressure. Further studies on the subject should be conducted to yield more concrete evidences.

• 대한약침학회지
• /
• 제17권2호
• /
• pp.73-79
• /
• 2014

Objectives: This study was performed to analyze a 13-week repeated dose toxicity test of Sweet Bee Venom (SBV) extracted from bee venom and administered in Sprague-Dawley (SD) rats. Methods: Male and female 5-week-old SD rats were treated once daily with SBV (high-dosage group: 0.28 mg/kg; medium-dosage group: 0.14 mg/kg; or low-dosage group: 0.07 mg/kg) for 13 weeks. Normal saline was administered to the control group in a similar manner (0.2 mL/kg). We conducted clinical observations, body weight measurements, ophthalmic examinations, urinalyses, hematology and biochemistry tests, and histological observations using hematoxylin and eosin (H&E) staining to identify any abnormalities caused by the SBV treatment. Results: During this study, no mortality was observed in any of the experimental groups. Hyperemia and a movement disorder were observed around the area of in all groups that received SBV treatment, with a higher occurrence in rats treated with a higher dosage. Male rats receiving in the high-dosage group showed a significant decrease in weight during the treatment period. Compared to the control group, no significant changes in the ophthalmic parameters, the urine analyses, the complete blood cell count (CBC), and the biochemistry in the groups treated with SBV. Compared to the control group, some changes in organ weights were observed in the medium-and the high-dosage groups, but the low-dosage group showed no significant changes. Histological examination of thigh muscle indicated cell infiltration, inflammation, degeneration, and necrosis of muscle fiber, as well as fibrosis, in both the medium- and the high-dosage groups. Fatty liver change was observed in the periportal area of rats receiving medium and high dosages of SBV. No other organ abnormalities were observed. Conclusion: Our findings suggest that the No Observed Adverse Effect Level (NOAEL) of SBV is approximately 0.07 mg/kg in male and female SD rats.

• 대한전기학회논문지:시스템및제어부문D
• /
• 제54권4호
• /
• pp.259-266
• /
• 2005

This paper presents a therapy that uses a constant drug dosage for leading HIV-infected patient to LTNP (Long-Term Non-Progressor). Based on analysis of CTLp (Cytotoxic T Lymphocyte precursor) concentration at equilibrium point and its bifurcation, we found the therapy with a drug whose efficacy is less than a certain level brings higher CTLp concentration at the equilibrium point. We observed a treatment with constant drug dosage whose efficacy is less than full treatment may lead HIV-infected patient to LTNP. It turns out that the treatment whose efficacy is less than full treatment is better in the point of performance on controllability.